Drug
P03277
P03277: highest development phase Phase 2, developed by Guerbet. 3 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Guerbet
Trials
| Drug | Phase | Indication |
|---|---|---|
| P03277 NCT02633501 | Phase 2 | CNS Lesion |
| P03277 NCT03603106 | Phase 1/2 | Healthy Volunteers |
| P03277 NCT03657784 | Phase 1 | Renal Insufficiency |
Latest
No recent events.
Follow P03277 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.